Tianjin Tianyao

a leading Chinese corticosteroid API producer, manufacturing hydrocortisone, prednisolone and related adrenal-cortical APIs from phytosterol biotransformation for global supply.

Country
China
Commercial Corticosteroid API (CN leader)
Coverage
CNEUUS
therapeutics-platforms
Regulatorsfdaemanmpa

Verifiable facts

FactValueSource
Founded1939simplywall.st · stockanalysis.com · futunn.com
HeadquartersTianjin, Chinasimplywall.st · stockanalysis.com · futunn.com
Headcount2,731 employeesstockanalysis.com
Revenue2.91 billion CNY (2025-12-31)financialfilings.com · stockanalysis.com
CertificationFDA, EDQM, WHO-prequalified, and national GMP certifications (2025-12-31)apicule.com · en.pharm.com.cn · financialfilings.com · stockanalysis.com · pharmacompass.com
Regulatory approvalUS FDA, European CEP, and various international and national drug registration certificatesen.pharm.com.cn · financialfilings.com · pharmacompass.com

Independent sources: apicule.com · en.pharm.com.cn · financialfilings.com · futunn.com · pharmacompass.com · simplywall.st · stockanalysis.com

Technologies
NameClusterRisk
Biosynthetic steroids (fermentation & biocatalytic API)therapeutics-platformsLow

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.